The Russian Direct Investment Fund (RDIF) has announced that the UAE Ministry of Health and Prevention (MOHAP) approved the one-shot Sputnik Light vaccine as a universal booster shot for all the vaccines used in the country for Covid-19.
The vaccine’s booster dose has been approved for all individuals aged 18 years above.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataIt can be administered six months after an individual receives the second dose of any other vaccine against Covid-19 in the country.
The single-component Sputnik Light vaccine was approved for use by the UAE in October.
It is based on human adenovirus serotype 26, Sputnik V Covid-19 vaccine’s first component.
The two-dose Sputnik V vaccine was also authorised by the UAE’s MOHAP in January.
RDIF claimed that the single-dose vaccine is highly effective when used as a booster and on a standalone basis.
According to the data gathered by the Gamaleya Center from 28,000 subjects in Moscow, the Sputnik Light vaccine showed an efficacy of 70% when administered standalone during the initial three months after vaccination against the Delta variant of Covid-19.
It is also 75% effective among participants aged below 60 years.
RDIF noted that Sputnik Light’s efficacy as a booster shot for other vaccines against the Delta variant will be similar to the efficacy of the Sputnik V vaccine against the variant, more than 94% against hospitalisation and 83% for infection.
RDIF said in a statement: “Sputnik Light has been proven to be safe and highly effective by real-world vaccination data. In particular, the vaccine has demonstrated an efficacy of between 78.6% to 83.7% among the elderly as confirmed by the Ministry of Health of Buenos Aires, Argentina.
“Paraguay’s Ministry of Health also found Sputnik Light to be 93.5% effective during the country’s ongoing vaccination campaign.”
